At the Annual Meeting in San Diego, California earlier this week, Dr. Armand Keating was installed as the President-Elect of the American Society of Hematology (ASH). This is well-deserved recognition for Dr. Keating and his pioneering work in hematology and a tremendous honour for Canadian medicine. Dr. Keating is only the second Canadian to have been so honoured by this prestigious organization; the first was the late Fraser Mustard who was President of ASH in 1970.
ASH is the pre-eminent hematology society internationally and has the mission to understand, diagnose, treat and prevent disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems. Dr. Keating is internationally recognized for his research and clinical contributions to malignant hematology, hematopoietic cell transplantation and regenerative medicine. Earlier this year, he delivered the Mortimer Bortin Lecture and Award at the Tandem Transplant Meetings, one of the highest international honours in blood and marrow transplantation.
Congratulations to Dr. Keating for bringing acclaim to The Princess Margaret and University Health Network!